ICD-10 及中医病证分类及编码_百度文库
两大类热门资源免费畅读
续费一年阅读会员，立省24元！
评价文档：
喜欢此文档的还喜欢
ICD-10 及中医病证分类及编码
阅读已结束，如果下载本文需要使用
想免费下载本文？
把文档贴到Blog、BBS或个人站等：
普通尺寸(450*500pix)
较大尺寸(630*500pix)
你可能喜欢您的位置： >
RSAMA-253种子全集
　发表时间：　人气：
| 下一篇：
番号 RSAMA-253 | 放n後わりきりバイト　２５
番 号：RSAMA-253 → RSAMA系列的所有作品番号 av作品名称：放n後わりきりバイト　２５
发行商：Ｓ素人
出版时间：
av片长：120 分钟
作品简介：
放n後の女子校生と割り切ったＳＥＸをSしむシリ`ズ第２５￥い膜馔à辘未橛挨嚷いてやって来たギャル系F役i者モデル。だが、アナルをガンされ玩具で弄られＳＥＸ、さらには中出しまでされてしまう。主演女优：1、 新垣セナ (あらがきせな) Sena Aragaki 简介: あらがき　せな
新垣　セナAV女优个人资料别名:
にいがき　せな 出生:
23r 出道地点:
日本?东京都 血型:
B 体形（2009年12月量度）身高／体重:
156 厘米 / D 公斤 三围:
86 - 58 - 88 cm
| 下一篇：打开微信扫一扫
孔网客户端
安卓版苹果版扫描下载
2012 Icd-9-Cm For Physicians Volumes 1 And 2 P
开&&&&&&本：开
页&&&&&&数：1200页页
字&&&&&&数：
I&&S&&B&&N：
售&&&&&&价：723.00元
原书售价：723.00元
品&&&&&&相：
运&&&&&&费：北京市朝阳区
挂号印刷品：10.00元
上书时间：
购买数量：
（库存10件）
商品分类：
关 键 字：
详细描述：
电话：&QQ：基本信息
书名:&2012&Icd-9-Cm&For&Physicians&Volumes&1&And&2&Professional&Edition&(Softbound)&
原价：&723.00元
作者:Carol&J.&Buck&MS&&CPC&&CPC-H&&CCS-P
出版社：Saunders
出版日期：日
ISBN：9
字数：
页码：1200页
版次：1Pro
装帧：平装
开本：
商品标识：asin
编辑推荐
暂无
内容提要
暂无
目录
&&Unit&One:&ICD-9-CM&Part&I:&Introduction&ICD-9-CM&Background&&Coordination&and&Maintenance&Committee&&Characteristics&of&the&ICD-9-CM&&The&Disease&Classification&&ICD-9-CM&Official&Guidelines&for&Coding&and&Reporting&&Part&II:&Alphabetic&Index,&Volume&2&Section&1&Index&to&Diseases&&Section&2&Table&of&Drugs&and&Chemicals&&Section&3&Index&to&External&Causes&of&Injury&Part&III:&Diseases:&Tabular&List,&Volume&1&1.&Infectious&and&Parasitic&Diseases&2.&Neoplasms&3.&Endocrine,&Nutritional&and&Metabolic&Diseases,&and&Immunity&Disorders&4.&Diseases&of&the&Blood&and&Blood-forming&Organs&5.&Mental&Disorders&6.&Diseases&of&the&Nervous&System&and&Sense&Organs&7.&Diseases&of&the&Circulatory&System&8.&Diseases&of&the&Respiratory&System&9.&Diseases&of&the&Digestive&System&10.&Diseases&of&the&Genitourinary&System&11.&Complications&of&Pregnancy,&Childbirth,&and&the&Puerperium&12.&Diseases&of&the&Skin&and&Subcutaneous&Tissue&13.&Diseases&of&the&Musculoskeletal&System&and&Connective&Tissue&14.&Congenital&Anomalies&15.&Certain&Conditions&Originating&in&the&Perinatal&Period&16.&Symptoms,&Signs,&and&Ill-defined&Conditions&17.&Injury&and&Poisoning&V-Codes&Supplementary&Classification&of&Factors&Influencing&Health&Status&and&Contact&with&Health&Services&E-Codes&Supplementary&Classification&of&External&Causes&of&Injury&and&PoisoningAppendix&A&Morphology&of&Neoplasms&&Appendix&B&Glossary&of&Mental&Disorders&&Appendix&C&Classification&of&Drugs&by&American&Hospital&Formulary&Services&List&Number&and&Their&ICD-9-CM&Equivalents&Appendix&D&Classification&of&Industrial&Accidents&According&to&Agency&&Appendix&E&List&of&Three-Digit&Categories&
作者介绍
暂无
文摘
暂无
媒体推荐
暂无
电话：&QQ：
您可能感兴趣的商品
& & & 金顶书社&&经营各类工具书、医学类、工会用书、煤矿安全用书、管理类、考试类、历史类、小说类等。先款后书,书价不含快递费及发票，起价10元，另10元/千克，新疆、云南、西藏、海南另计。
书要的急请先与店主沟通好再拍，3天内发货，勿催促。
2010年以前出版的图书请先与店家沟通查库是否有货再下订单，难免有缺货的图书未下架，以免耽误你宝贵时间，谢谢
汇款方式：
&1.农行帐号：60& && 刘君
&2.建行帐号：& & 930& 刘君&&&
3.工行帐号&：& & 037&&&刘君&&
&4.中信银行：& & 刘君&&&&&&
&&&&&&&&&&&&&&&&&
&&&&&&&&&&&&&&&&&QQ:&&&&
Copyright(C)
孔夫子旧书网
京ICP证041501号
海淀分局备案编号
购物车共有0件商品，合计：0.00元
商品已成功添加到收藏夹！Defining Cancer Statistics
Fast Stats
Build tables and graphs of cancer statistics by:
Other Tools
Statistical Reports
Other Publications
Statistical Software
Documentation & Recodes
Reporting Guidelines
Software & Services
Questions & Answers
SEER is an authoritative source of information on cancer incidence and survival in the United States. SEER currently collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 28 percent of the U.S. population.
2013 ICD-9-CM Casefinding List: Expanded
You can enter up to 10 email addresses (separate with commas):
Send To: (required)
Your Email: (required)
Email a copy to myself
Fiscal Year 2013 ICD-9-CM Casefinding List: Expanded Version
These tables are also available in a .
2013 Comprehensive ICD-9-CM Casefinding Code List for Reportable Tumors
(with equivalent ICD-10-CM codes**)
(Effective Date: 1/1/2013)
Please refer to your standard setter(s) for specific reporting requirements before using the Casefinding List
140._ - 172._,
174._ - 209.36, 209.7_
C00._ - C43._,
C45._ - C96._
Malignant neoplasms (excluding
173) , stated or presumed to
be primary (of specified sites), and certain specified histologies
173.00, 173.09
C44.00, C44.09
Unspecified and other specified malignant neoplasm of skin of lip
173.10, 173.19
C44.101, C44.191
Unspecified and other specified malignant neoplasm of eyelid, including canthus
173.20, 173.29
C44.201, C44.291
Unspecified and other specified malignant neoplasm of ear and external auricular canal
173.30, 173.39
C44.30, C44.39
Unspecified and other specified malignant neoplasm of skin of other and unspecified parts of face
173.40, 173.49
C44.40, C44.49
Unspecified and other specified malignant neoplasm of scalp and skin of neck
173.50, 173.59
C44.50_, C44.59_
Unspecified and other specified malignant neoplasm of skin of trunk, except scrotum
173.60, 173.69
C44.601, C44.691
Unspecified and other specified malignant neoplasm of skin of upper limb, including shoulder
173.70, 173.79
C44.701, C44.791
Unspecified and other specified malignant neoplasm of skin of lower limb, including hip
173.80, 173.89
C44.80, C44.89
Unspecified and other specified malignant neoplasm of other specified sites of skin
173.90, 173.99
C44.90, C44.99
Unspecified and other specified malignant neoplasm of skin, site unspecified
225.0 - 225.9
Benign neoplasm of brain and spinal cord neoplasm
227.3, 227.4
D35.2, D35.3
Benign neoplasm of pituitary gland, craniopharyngeal duct (pouch) and pineal gland
H of intracranial structures
Lymphangioma, any site
Note: Includes only lymphangioma of the brain, other parts of nervous system and endocrine gland
Carcinoma in situ
D44.3 - D44.5
Neoplasm of uncertain behavior of endocrine glands and nervous system: pituitary gland, carniopharyngeal duct and pineal gland
237.5, 237.6, 237.9
D42._, D43.0_
Neoplasm of uncertain behavior of endocrine glands and nervous system: brain and spinal cord, meninges, endocrine glands and other and unspecified parts of nervous system
Polycythemia vera
Plasma cells
D46._, D47._
Other lymphatic and hematopoietic diseases
239.6, 239.7
Neoplasms of unspecified nature, brain, endocrine glands and other parts of nervous system
Macroglobulinemia (Waldenstrom&s macroglobulinemia)
C96.5, C96.6
Other specified disorders of metabolism
Reportable includes terms: Hand-Schuller-C histiocytosis (acute)(chronic); histiocytosis X (chronic)
D76.1 - D76.3
Hemophagocytic syndrome (histiocytic syndromes)
The following codes are not
reportable per se, but they should alert registrars to look for the first
malignant neoplasm associated with these codes.
2013 Supplementary List #1 ICD-9-CM Codes That Should be Followed by or Associated with a Neoplasm Code (with Equivalent ICD-10-CM Codes)
E31.22, E31.23
Polyglandular activity in multiple endocrine adenomatosis [MEN]
Note: Use additional codes to identify any malignancies and other conditions associated with the syndromes
Myelophthisis
Note: Code first the underlying disorder, such as: malignant neoplasm of breast (174.0-174.9, 175.0-175.9)
Anemia in neoplastic disease
Note: Assign also a code for the neoplasm causing the anemia
Myelofibrosis (9961/3)
Note: Code first the underlying disorder, such as: malignant neoplasm of breast (174.0-174.9, 175.0-175.9)
Cerebral degeneration in diseases classified elsewhere
Note: code first underlying disease, such as neoplastic disease (140.-239.9)
Myelopathy in other diseases classified elsewhere
Note: Code first underlying disease as: myelopathy in neoplastic disease (140.0-239.9)
G13.0, G13.1
Polyneuropathy in malignant disease
Note: Code first underlying disease (140.0-208.9)
Myasthenic syndromes in other diseases classified elsewhere
Note: code first underlying disease, such as neoplasm (C00-D49)
Eaton-Lambert syndrome in neoplastic disease
Malignant pleural effusion
Note: Code first malignant neoplasm, if known
Secondary spontaneous pneumothorax
Note: Code first underlying condition such as: cancer metastatic to lung (197.0) or primary lung cancer (162.3-162.9)
Osteitis deformans in diseases classified elsewhere
Note: Code first underlying malignant neoplasm of bone (170.0-170.9)
Major osseous defect
Note: Code first underlying malignancy, if known, such as:
Malignant neoplasm of bone (170.0-170.9)
Malignant ascites
Note: Code first malignancy
Prophylactic use of agents affecting estrogen receptors and estrogen levels
Note: code first, if applicable: malignant neoplasm of breast (174.0-174.9, 175.0-175.9)
Aftercare following surgery for neoplasm
Note: Conditions classifiable to 140-239
Cases with these codes should be screened as registry time allows. These are
neoplasm-related secondary conditions for which there should also be a primary
diagnosis of a reportable neoplasm. Experience
in the SEER registries has shown that using the supplementary list increases
casefinding for benign brain and CNS, hematopoietic neoplasms, and other
reportable diseases.
2013 Supplementary List #2 ICD-9-CM Code List to Screen for Cancer Registry Cases Not Identified by Other Codes (with equivalent ICD-10-CM codes)
Acquired Immunodeficiency Syndrome (AIDS)
Note: Medical coders are instructed to add codes for AIDS-associated malignancies. Screen 042 for history of cancers that might not be coded
079.4, 79.5_
H Retrovirus (HTLV, types I, II and 2)
173.01, 173.02
C44.01, C44.02
Basal and squamous cell carcinoma of skin of lip
173.11, 173.12
C44.111, C44.121
Basal and squamous cell carcinoma of eyelid, including canthus
173.21, 173.22
C44.211, C44.221
Basal and squamous cell carcinoma of ear and external auricular canal
173.31, 173.32
C44.31_, C44.32_
Basal and squamous cell carcinoma of skin of other and unspecified parts of face
173.41, 173.42
C44.41, C44.42
Basal and squamous cell carcinoma of scalp and skin of neck
173.51, 173.52
C44.51_, C44.52_
Basal and squamous cell carcinoma of skin of trunk, except scrotum
173.61, 173.62
C44.611, C44.621
Basal and squamous cell carcinoma of skin of upper limb, including shoulder
173.71, 173.72
C44.711, C44.721
Basal and squamous cell carcinoma of skin of lower limb, including hip
173.81, 173.82
C44.81, C44.82
Basal and squamous cell carcinoma of other specified sites of skin
173.91, 173.92
C44.91, C44.92
Basal and squamous cell carcinoma of skin, site unspecified
209.40 - 209.69
Benign carcinoid tumors
210.0 - 229.9
D34, D35.0 - D35.1 - D35.5 - D35.9, D36._
Benign neoplasms (except for 225.0-225.9, 227.3, 227.4, 228.02, 228.1, which are listed in the Reportable list)
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
Neoplasms of uncertain behavior
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
D44.1, D44.2, D44.6
Neoplasm of uncertain behavior of adrenal gland, paraganglia and other and unspecified endocrine glands
Note: screen for incorrectly coded malignancies or reportable by agreement tumors
Neurofibromatosis and Schwannomastosis
D48._, D49._
Neoplasms of uncertain behavior
(except for 238.4, 238.71-238.79, 239.6, 239.7, which are listed in the
reportable list)
Note: Screen for
incorrectly coded malignancies or reportable by agreement tumors
Secondary diabetes mellitus with hypersmolarity
Note: Includes diabetes in neoplastic disease
Polyclonal hypergammaglobulinemia
Note: screen for blood disorders due to neoplasm
Monoclonal gammopathy of undetermined significance (9765/1)
Note: Screen for incorrectly coded Waldenstrom macroglobulinemia or progression
Other paraproteinemias
273.8, 273.9
Other and unspecified disorders of plasma protein metabolism
Note: includes plasma disorders due to neoplastic disease
Tumor lysis syndrome (following neoplastic chemotherapy)
279.02, 279.03, 279.05, 279.12
D80.3, D80.4, D80.5
Select IgM immunodeficiency and other immunoglobulin deficiencies
Note: Associated with lymphoproliferative disorders
279.2, 279.3
D81.6, D81.7, D81.89, D81.9, D84.9
Combined and unspecified immunity deficiency
Note: Associated with lymphoproliferative disorders
279.41, 279.49
D89.82, D89.89
Autoimmune lymphoproliferative syndrome
Note: Associated with lymphoproliferative disorders
Graft-versus-host disease
279.8, 279.9
D84.1, D89.82, D89.9
Other and unspecified disorders involving the immune mechanism
Note: Associated with lymphoproliferative disorders
Pancytopenia
Note: screen for anemia disorder related to neoplasm
Red cell aplasia (acquired) (adult) (with thymoma)
Note: screen for anemia disorder related to neoplasm
D61.1 - D61.3, D61.89, D61.9
Other specified aplastic anemias
Note: screen for anemia disorder related to neoplasm
Aplastic anemia
Note: screen for anemia disorder related to neoplasm
Sideroblastic anemia
Note: screen for anemia disorder related to neoplasm
Anemia due to antineoplastic chemotherapy
287.39, 287.49, 287.5
D69.49, D69.59, D69.6
Secondary, other primary and unspecified thrombocytopenia
Note: Screen for incorrectly coded thrombocythemia
Drug induced neutropenia
Note: screen for anemia disorder related to neoplasm
Eosinophilia
Note: This is the code for eosinophilia (9964/3). Not every case of eosinophilia is associated with a malignancy. Diagnosis must be &Hypereosonophilic syndrome& to be reportable
289.89, 289.9
D75.89, D75.9,
Other and unspecified diseases of blood and blood forming organs
Note: screen for anemia disorder related to neoplasm
Other causes of encephalitis and encephalomyelitis
Note: includes encephalitis due to neoplasm
Unspecified disorders of autonomic nervous system
Note: Includes myelopathy in neoplastic diseases
Neoplasm related pain (acute)(chronic)
Unspecified disorder of cranial nerves
Note: includes cranial nerves disorder in neoplastic disease
Other nerve root and plexus disorders
Note: includes nerve root and plexus disorders in neoplastic disease
Adult pulmonary Langerhans cell histiocytosis
of anus (Anal intraepithelial neoplasia [AIN I and II])
of prostate (Prostatic intraepithelial neoplasia [PIN I and II])
of cervix, cervical dysplasia, NOS
dysplasia of cervix [CIN I]
dysplasia of cervix [CIN II]
of vagina (Vaginal intraepithelial neoplasia [VAIN I and II]
N90.0, N90.3
intraepithelial neoplasia I [VIN I] & unspecified
intraepithelial neoplasia II [VIN II]
Hydatidiform mole
Note: This is a benign tumor that can become malignant. If malignant, it should be reported as Choriocarcinoma (9100/3) and will have a malignancy code in the 140-209 range
Other current conditions classifiable elsewhere complicating pregnancy
Note: Includes: malignant neoplasm complicating pregnancy
Arthropathy associated with other conditions
Note: includes arthropathy in neoplastic disease
Unspecified disorder of muscle, ligament, and fascia
Note: Includes disorder of muscle, ligament, fascia in neoplastic disease
Pathologic fracture
Note: includes pathologic fracture due to neoplasm
Down's Syndrome
Note: Screen for leukemia associated with Down&s Syndrome (9898/3)
Neoplastic (malignant) related fatigue
Enlargement of lymph nodes
Note: Screen for large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease (9738)
Malignant ascites
Elevated prostate specific antigen (PSA)
Other non specific findings on examination of urine(abnormal findings on cytological and histological examination of urine)
792.0, 792.2, 792.4, 792.9
R83.9, R84.9, R85.9, R86.9
Non specific abnormal findings in other body structures: cerebrospinal fluid, semen and saliva and other
Solitary pulmonary nodule
Nonspecific (abnormal) findings on radiological and examination of body structure (breast)
795.0_ - 795.1_
Papanicolaou smear of cervix and vagina with cytologic evidence of malignancy
Other nonspecific abnormal histological findings
Abnormal cytologic smear of anus and anal HPV
Ab Elevated tumor associated antigens [TAA]
Poisoning by hormones and synthetic substitutes: Androgens and anabolic congeners
Poisoning by primarily systemic agents: antineoplastic and immunosuppressive drugs
Effects of radiation, unspecified (radiation sickness)
Mechanical complication of other specified prosthetic device, implant, and graft-due to breast prosthesis
Complication of transplanted organ
Complications due to central venous catheter
Accidental poisoning by other drugs: Hormones and synthetic substitutes
Accidental poisoning by other drugs: Primary systemic agents
T45.8_, T45.9_
Agents primarily affecting blood constituents
Failure in dosage, overdose of radiation in therapy (radiation sickness)
Abnormal reaction of surgical operation with transplant of whole organ
Overdose of radiation given during therapy (radiation sickness)
Adverse reaction of antineoplastic therapy-Antineoplastic antibiotics
Adverse reaction to antineoplastic therapy-Androgens and anabolic congeners
Adverse effect (poisoning) of immunosuppressive drugs
V10.0_ - V10.9_
Z85.0_ - Z85.8_
Personal history of malignancy
Note: Screen for recurrences, subsequent primaries, and/or subsequent treatment
Personal history of benign neoplasm of the brain
Z86.000, Z86.008, Z86.011
Personal history of unspecified malignant neoplasm and history of in-situ neoplasm of other site
Personal history of undergoing in utero procedure during pregnancy
Note: includes procedures on fetus for cancer related diagnosis
Other personal history presenting hazards to health or radiation
Note: Personal history of therapeutic radiation
Family history of malignant neoplasm
V42.81, V42.82
Z94.81, Z94.84
Organ or tissue replaced by transplant bone marrow, stem cell
Encounter for breast reconstruction following mastectomy
Fitting and adjustment of prosthetic device and implant (breast)
Aftercare for healing pathologic fracture
V58.0, V58.1_
Z51.0, Z51.1_
Encounter for radiotherapy, chemotherapy, immunotherapy
Aftercare following surgery for neoplasm
V66.1, V66.2
Convalescence and palliative care following radiotherapy, chemotherapy
Encounter for palliative care
V67.1, V67.2
Follow up examination: following radiotherapy or chemotherapy
Observation for suspected malignant neoplasm
Other specified pre-operative examination (including chemotherapy)
Special screening for malignant neoplasms
V78.8, V78.9
Other and unspecified disorders of blood and blood forming organs
Estrogen receptor positive status [ER+], negative status [ER-]
Personal history of antineoplastic chemotherapy
Personal history of estrogen therapy
Personal history of immunosuppression therapy
The following codes are associated with the paraneoplastic
syndrome. Paraneoplastic syndrome by itself is not cancer. It&s a disease or
symptom that is the consequence of cancer but is not due to the local presence
of cancer cells. A paraneoplastic syndrome may be the first sign of cancer.
These codes have been removed from the supplemental list and are now in their
Syndrome of inappropriate secretion of antidiuretic hormone
Carcinoid syndrome
Other specified endocrine disorders
Hypercalcemia
Nystagmus and other irregular eye movements
Pyoderma gangrenosum
L30.4, L53.8, L98.2
Other specified erythematous conditions
Acquired acanthosis nigricans
Dermatomyositis
Polymyositis
*International Classification of Diseases, ICD-10-CM Tabular List of Diseases and Injuries,
information regarding ICD-10-CM, including the conversions of ICD-9-CM to
ICD-10-CM based on the 2013 General Equivalency Mappings provided by CMS and
NCHS on the CDC website for ICD coding: